Does NEORAL Cause Hepatic function abnormal? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic function abnormal have been filed in association with NEORAL. This represents 2.7% of all adverse event reports for NEORAL.
7
Reports of Hepatic function abnormal with NEORAL
2.7%
of all NEORAL reports
3
Deaths
4
Hospitalizations
How Dangerous Is Hepatic function abnormal From NEORAL?
Of the 7 reports, 3 (42.9%) resulted in death, 4 (57.1%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEORAL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does NEORAL Cause?
Blood creatinine increased (18)
Death (17)
Immunosuppressant drug level increased (14)
Renal failure (13)
Interstitial lung disease (11)
Kidney transplant rejection (11)
Renal impairment (11)
Maternal exposure during pregnancy (10)
Oral administration complication (9)
Pyrexia (9)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which NEORAL Alternatives Have Lower Hepatic function abnormal Risk?
NEORAL vs NEOSTIGMINE
NEORAL vs NEOSTIGMINE METHYLSULFATE
NEORAL vs NEPAFENAC
NEORAL vs NERATINIB
NEORAL vs NETARSUDIL